- Letter
- Published:
Alternative splicing directs the expression of two D2 dopamine receptor isoforms
- Bruno Giros1,
- Pierre Sokoloff1,
- Marie-Pascale Martres1,
- Jean-François Riou1,2,
- Laurent J. Emorine3 &
- …
- Jean-Charles Schwartz1
Naturevolume 342, pages923–926 (1989)Cite this article
1075Accesses
654Citations
3Altmetric
Abstract
DOPAMINE receptors are classified into Dl and D2 subtypes on the basis of their pharmacological properties and the intracellular responses they mediate1. The cerebral D2 dopamine receptor is the target of drugs used to alleviate the main symptoms of schizophrenia2–4. Although it is considered to be a single molecular entity, there is evidence that multiple D2-receptor subtypes exist5,6. A complementary DNA encoding a D2 receptor has recently been cloned7 and the deduced 415-amino-acid sequence indicates that it belongs to the large superfamily of receptors coupled to G proteins, and that its topology consists of seven transmembrane domains. In this family, the genes are frequently without introns and each is believed to encode a unique polypeptide product. Here we show that the gene for the D2 receptor produces two receptor isoforms by alternative messenger RNA splicing, providing a route to receptor diversity in this family. One isoform corresponds to the D2(415) receptor7, but the second contains an additional sequence encoding a 29-amino-acid fragment, defining a novel D2(444) receptor isoform. Expression of the two isoforms is tissue-specific, and both are regulated by guanyl nucleotides. As the extra sequence is located within a putative cytoplasmic loop that binds to G proteins, the two isoforms might interact with different G proteins and thereby initiate distinct intracellular signals.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kebabian, J. W. & Calne, D. B.Nature277, 93–96 (1979).
Carlsson, A. & Lindqvist, M.Acta Pharmac. Toxicol.20, 140–144 (1963).
Creese, I., Burt, D. R. & Snyder, S. H.Science192, 481–483 (1976).
Seeman, P.Pharmacol. Rev.32, 229–313 (1980).
Sokoloff, P., Martres, M. P. & Schwartz, J. C.Nature288, 283–286 (1980).
Schwartz, J. C.et al. inCatecholamines: Neuropharmacology and Central Nervous System. Theoretical Aspects (eds Usdin, E., Carlsson, A., Dahlström, A. & Engel, J.) 59–72 (Liss, New York, 1984).
Bunzow, J. R.et al.Nature336, 783–787 (1988).
Shapiro, M. B. & Senapathy, P.Nucleic Acids Res.15, 7155–7174 (1987).
Martres, M. P., Bouthenet, M. L., Salès, N., Sokoloff, P., & Schwartz, J. C.Science228, 752–755 (1985).
Salès, N., Martres, M. P., Bouthenet, M. L. & Schwartz, J. C.Neuroscience28, 673–700 (1989).
Saiki, R. K.et al.Science239, 487–491 (1988).
Doherty, P. J., Huesca-Contreras, M., Dosch, H. M. & Pan, S.Analyt. Biochem.177, 7–10 (1989).
Dixon, R. A. F.et al.Nature326, 73–77 (1987).
Kubo T.et al.FEBS Lett.241, 119–125 (1988).
Rubenstein, R. C., Wong, S. K. F. & Ross, E. M.J. biol. Chem.262, 16655–16662 (1987).
Bray, P.et al.Proc. natn. Acad. Sci. U.S.A.83, 8893–8897 (1986).
Andreadis, A., Gallego, M. E. & Nadal-Ginard, B.A. Rev. cell. Biol.3, 207–242 (1987).
Owen, F.et al.Lancetii, 223–226 (1978).
Seeman, P.et al.Science225, 728–731 (1984).
Huynh, T. V., Young, R. A. & Davis, R. W. inDNA Cloning. A Practical Approach Vol.1 (ed. Glover, D. M.) 49–78 (IRL, Oxford, 1985).
Gubler, U. & Hoffman, B. J.Gene25, 263–269 (1983).
Chirgwin, J. J., Przbyla, A. E., MacDonald, R. J. & Rutter, W. J.Biochemistry18, 5294–5299 (1979).
Aviv, H. & Leder, P.Proc. natn. Acad. Sci. U.S.A.69, 1408–1412 (1972).
Sanger, F., Nicklen, S. & Coulson, A. R.Proc. natn. Acad. Sci. U.S.A.74, 5463–5467 (1977).
Sokoloff, P., Martres, M. P., Delandre, M., Redouane, K. & Schwartz, J. C.Naunyn-Schmiedebergs Archs Pharmak.327, 221–227 (1984).
Graham, F. L. & Van der Eb, A. J.Virology52, 456–467 (1973).
Author information
Authors and Affiliations
Unité de Neurobiologie et Pharmacologie, U. 109 de I'lnserm, Centre Paul Broca, 2 ter, rue d'Alésia, 75014, Paris, France
Bruno Giros, Pierre Sokoloff, Marie-Pascale Martres, Jean-François Riou & Jean-Charles Schwartz
Laboratoire de Physiologie, Faculté de Pharmacie,Université René Descartes, Paris, France
Jean-François Riou
Laboratoire de Biologie Moléculaire des Récepteurs, CNRS et institut Pasteur, 25 rue du Docteur Roux, 75724, Paris, Cedex 15, France
Laurent J. Emorine
- Bruno Giros
You can also search for this author inPubMed Google Scholar
- Pierre Sokoloff
You can also search for this author inPubMed Google Scholar
- Marie-Pascale Martres
You can also search for this author inPubMed Google Scholar
- Jean-François Riou
You can also search for this author inPubMed Google Scholar
- Laurent J. Emorine
You can also search for this author inPubMed Google Scholar
- Jean-Charles Schwartz
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Giros, B., Sokoloff, P., Martres, MP.et al. Alternative splicing directs the expression of two D2 dopamine receptor isoforms.Nature342, 923–926 (1989). https://doi.org/10.1038/342923a0
Received:
Accepted:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
The human neuropsychiatric risk gene Drd2 is necessary for social functioning across evolutionary distant species
- Kevin G. O. Ike
- Sanne J. C. Lamers
- Martien J. H. Kas
Molecular Psychiatry (2024)
Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution
- Lisa Forster
- Steffen Pockes
Scientific Reports (2022)
The dopaminergic control of Cushing’s syndrome
- R. Pivonello
- C. Pivonello
- A. Colao
Journal of Endocrinological Investigation (2022)
Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications
- Justyna Żuk
- Damian Bartuzi
- Agnieszka A. Kaczor
Pharmacological Reports (2022)
New Antipsychotic Medications in the Last Decade
- Mehak Pahwa
- Ahmad Sleem
- Rif S. El-Mallakh
Current Psychiatry Reports (2021)